!"#$%"&$'()*+*,-$./010
2#$3$#2/4$5-1
*++6."789:3;<$=
$##.$''>?0?;
02@A%0-$B0100?-$C($
40-23<D>$E4F
</,$#>6$;
$##@3+!.F$G$;
0FFHIJKLMJ77MJ78M(
N.O';PQRSTUC
0->0?&$#!0F$#V2'?#
PQRSTU0?.WX2'
#0?.</K+YZJ76MJ77M(
I=0.0-$BPQRSTU0[$>
F>A\A]^_-2=0.;/
<&$/FV^.250`$''(
$=0.0-$BPQRSTU!<F<
[<a'?C-$<.(
I?$CG25F
*b*cZA#2'(7?$#-$.0'[d#>3e
^.`?$0'[d2$$J6YM
JLKM(I]?$F0CAAf<_A\
a0]?$<N&$#
*
023<D`;.$C -(
g$.`#?$B'"
0-$B#?$<F<AF-$.A%
<N$'`$''(H.$a0-$
B`"h<N0//"A\iB0X
%#C08V`neoEF
*ZA#2'B\SqY$U<$5:N
I#$r[LLZ2'#>$JmYM(
I6ccY8neoVF</66X
\*sLA#2'F</*YK$#
S6KYs*cc(cccU0Fq,$?PQRSTUS*c,s*cc(cccU
WF+b,$a6$AJ76M(
L
tn#$u -(v)*,,cb*,,K2'
#+qZ(wxy)*,+Kb*,,c*+cZ*YKZJ56M(
tg9z)*,YL{*,+Y2'#/)+K(LcK
?^$'O66(6YY(:*,,L2'#01
qL(+cc#J42MJ56MJ72M(tP*,+cF</q(ccc#
*,,601Fm(ccc#()*,+q0*,,c2'
#!%|}LLLZ:wLcmZJ58M(
9$5#.R;~[!LL<$
52'#0?.*,,KKqLs*cc(cccA#
*,,qY+s*cc(cccA#Jm6M(:N•$€lNhh2$
-$G<X/0-$0 898<P(oS*,,,U!I*,,mX
amL,s*cc(cccA#X@*qms*cc(cccA#0N2
*,,*J73MJ74M(
g•HsP•~|^$3-
>$![(8neoS*,,mUV
F*q$\g•H</Ybq$01\/
g•H\[C0>$!]#g•HsP•~|J35M(
~789S*,,LUVk;;\g•H
3->$)*,,c06ccY2$J58MkX
)*qLZ*,,YYm+Z6ccYXg•HSTU!
#)K6Z*,,c*L+Z6ccc(R
$#V#@!\g•H8neo3L
<$=p0?<'C>-2'a
$d[;01^$0<.2$<.0C
&$NJLqM(
Y
0101?17DD+, *E,
tO -033*666F
2'#^3*K6mF;;0
<.2$<.(gVF*+c(ccc#
0FF</q(ccc#0<.</m(Kcc#
sg•H(H25E5`nn€„ojp.0?
</qcZ2'#V</*cZ2'RI<.
0$'^$J36MJ77M(
80..`neoS6cc*U<$5#.R;
~[HI033-2'?#2$$
„$'uHIC66&$'F;
>"C*cF2'#n#$
r0?^!3$;<$5J75M(
„$<&$/0-$-$[\nn€„o'?
neo#VV$[\!HI
S7U*mZ0FV$[\$;!.
pVa</*6Z.pV66ZJ9MJ10MJ76M(
X@AO<.S6Ls*cc(cccU[3
</*,(cccAE(IG3E!
02`Y6(
80-$`R€R$[6cc*X
D8</qc{q*s*cc(cccDVEF</6c(ccc
?D8>/0-$B(t !
…3$*q{YYS!]6Y{Kc$U
]02/^$-$`/G^1C0
]0C%CV^1CJ,M(
6c** Yc(mY* 6c(LmL +(qL, *+(cmm 6(qm+ *cc(Y*+
gp.0?</qcZ#
V.mmZPQRSTU$#V
#JLqM(
m
'/0ABg•HsP•~|>$H
IW<$50?F'0CABF
(2'.\[C!#g•HsP•~|
030>$h$##@!]#
J29M( 8 2' $ $} L 6cc6b6ccL ` O &$/ †
g•HsP•~|Sn%A5OO'g•HsP•~|{ReU)
6cc*{6ccL01FKm(Y*,\g•H0F2'#sg•H
6*m+KLLZ-RaKLKZ-$L,LZ-I
Y*KZ(:-$$!]#<?g•HsP•~|</
. -$<F<AG"]$#525
$dC0J10M(
C0]d$-O/
A#2'!<$50NB<$5NN-j
<NV#<N] //#Oa2?
/!00;2?BC0#^.A0F
$0<.$C0<..[2!#
<N$<(H;G<N0?.0-$
B<BJ42MJ44M(
0101I17DD+, 5789
g.CpW!Raw-$A#2'LK*$
(50'?`nn€„opgF01
d<O'p.RIW
[.%0C`$2@A%[.205$
.$#RIPQRSTU(>0#
g..0?)L(KccbL(,cc#E0</Y,bqYZ
J KK? L@ ?M@ M= 0@@
>$?1@+A*"#$34567
01?101N !"
1.2.1.1. Đặc điểm lâm sàng J43M
b$3#kR#i/</0C
<_>2jFdA42$<A^?$
<_A2'‡Lm
c
YbL+
c
nV 2'2'<_A)6{L$><N
A0C2'AAˆ--$'<…8N-
0‰n.$30?-$$"C3\
\0C(
b$3[k
T$3 <00>$
Fd$^ `0 (:#$3&$">
$'>RIlI20d=0.(
,
Tg.$k9/*cZ#a0>$W$3
.$.$VF0$N<.$(
T:$5k:#$3<N ^$0$
<$j!CBV'0B(
T9F!ko <[C!(
b$35dkt00>$A$$5d…
<<.S;2Š8U<N.0?$3
;Š][i(wC2'?Fd8
;/!0p /bC2'(
I8'0B!CBVS`UC
A$$F.B(
6
un•
6
UFdB0<
[C<_A(
b:#0k02'.?[
<N/!00(I!0$CS<F3
#U;F2Fu./A/(
01?1?12OP;*
1.2.2.1 Cơ sở vi khuẩn học [43]:
bV0C<.$'`<$=kH<$=.d
0C30C0B2‚^$C2'<$=<.$'.
d`<.$'(:F?0C<.$'O"
<.$'5`<$=(g?0C<.$'^/
/.$''($z)$'X0C<.$'
`<$=F<.$k7k*c
b+
gk*c
bq
yk*c
bq
|k*c
bq
‹k*c
bq
((((
IG&$>d<$=2'?<$=<.
$'(|'?<$=<.$$z)[(
<V$;6FN&$/;F
**
'307gV.A%|<NF.A%(
+ IF~ko]<$=W05
<N$d.<N.d"]<$=•W`•(
n.$''<NF.A%(|'?<$=`FV
FdB$A!'\AB`[d(
*6
n.$''F</A.<$=$C
FP<FFRn(H;G/0-$B#$AW$
A0dFRn.?..(
bn[.A%`$''k
T•25?.A$8`<$=;C
3?P7Ib8288)0C<N
?0?.P7I(:#[.A%`7(
T•25?.8`<$=0#[.A%
`|<8(
Tu.$X`<$=V<.`<$=3
25?2A`<$=0FFA(
:#[.A%`22A8A8$(
1.2.2.2. Cơ sở dược lý [43]:
b€-$?0C$'k.A%`$'%$C
0C00?$[.0C&$
50-$?$'.A$'($F
0C>$†0C$'0Snw|bn8
|8&$8w^$U0C3'd$Snw•bn8w
•8U(I0C$'0<.$$z)$'-$
?$'0C$'F.A%A<$=(:d0
0?0p$$'$'j0F$'.3
$'Cj0d?$'a8.$(I
0C3'd$0C`)$'F</3
25.d`<$=(|2.0C$'00C
0-$BJKLM(
I.$''$OF.$''0?
^ •• k ‹A A <
2ASuP|U(((I]$'F.A%A<$=$ p
<;125.d`<$=[ <.jF
-$0CV<2@A%(H;GjV0?2@A%..0
0-$B(
gnn€„oHIA`$Y$'0-$Bk
|7gy‹J**M(
01?1R1ST
:d0-$BF<&$/>50j0>0`
.$a2$J**MJKLMk
1.2.4.1. Phối hợp các thuốc chống lao:wE$''FC.
A%<.$<$=k~<$=<;<$=(H;G/'
?VL$'0N(I][F<.$'
0>$>'?K$'0N2$0FA6
L0A$;(
1.2.4.2. Thuốc phải dùng đúng liều: n.$''F.A%
0E$'FC0C.A%0B(I$A-$
2‚<N$&$/A\.`<$=<.$'A-$
2‚#(
1.2.4.3. Phải dùng thuốc đều đặn: n.$''/$'
Cj'0B0dFd00?0p0C
$'$($'/$'^]0d0$'0(
*Y
1.2.4.4. Dùng thuốc phải đủ thời gian:~<$=22/GFd
W#$AA<$=AAˆ;G0d/X..
;0-$B/0`Sqb+U.(
1.2.4.5. Điều trị theo hai giai đoạn: NA$;(
bo0NS<_A6bL.Uku'?V$'
0-$B2$iBC2'd #<.(
1.5.2.3.Phác đồ III:6g7y‹sKg7 6g7ysKg7
bgA4ko0N<_A6.K$'
Sg7y‹U L$'Sg7yUA0-$B/.d
D8(o0A$;<_AK.6$'g7A
(
bnp0Bkn/.dD8(?D8
d Fd#aA'?|(
01?1L17V WX
I8AŠ0..0.3#2.A%%`$'
0-$B>/0?^_08AŠJ**MJKLMk
b:'dPQRSTUkn>/^_0L>
Tu.0•k
6|7gysqg‹kl_0$'.36YmS +U(
67gy‹sKg7kl_0$'.36Kq(
Tu.0••kl_0$'.3LYmS +U(
Tu.0•••kl_0$'.36Y(
b:'dPQRSbUkl_0>!$'.
36Y(
YZ[AB,\V WX]
b:'u.0•kI$2$6.N^_0PQR
4A[V;0-$BN*.Wg7y2$0F$d
0-$BA$;(I$).3Y!0^_0PQR#V;
%0-$BA$;$A[V/$du.0••(
*m
b:'u.0••kI$2$L.N^_04
A[V;0-$BN*.W7gy‹2$0F$d0-$
BA$;(I$^_PQRSTU0).3Y!0$d
0[2!0-$B<.$'(
b:'.0•••kIu.0•(
?$?$gIC[3**6mZL6LZ0F
qL6*Z0'??$a0>$$'?$$6cJ52M(
01I101N`, JKMJ6YMJ?:M
TH- 2'?kI?$2@A%&$.*$0'
*<# cmYV?$*c
O6KC
0N#mc<Su(gA*,,KU(
TH- ^1CkI?$/.;.$'?$?
&$.32@A%N$-'Su(gA*,,KU(
T83eS*,,LUkI?$$>$…
$'0Oi^$0$'F;F&$8'
#./</0C/!023<D(
01I1?184, J27MJ25M
1.3.2.1. Hậu quả đối với cá nhân
7?$2$<[d2‚0?#'0>$[&$C
2‚/!003.[&$C.2.'
†<.$(8..“gCB2[<3$AB
\#2A%?$”S*,,KUX]A%?$#G$
&$/^$-23<i8.C<A0C)cm0LKZ
><LcbKcZO.#>YcbmKZ(
*,
1.3.2.2. Các tổn hại về mặt xã hội
•'?$&$.-$#2#$2a^1C0;0F
.#$$4N#.ˆ0;(9N<V
ˆ0;?]03DjB'
‡@a0.0Gh<N0?2F@(I
?$A></0C"5N?
<X$G(
01I1I1QS94 5J25MJ34M
TH4%$'?$ A]G$&$/`F(
01I1K16,
oL0J25MJ34Mk
1.3.5.1.Giai đoạn 1 (Giai đoạn suy nhược thần kinh)
wC]A$$2`02?$
†25./^$-?$2$0F25<d2.-2'
??$$'($30>$`?$/^N
<$'&$.3</A$?$03'0_
0VŠFd$'Vj†!
0C.&$\$A\<0(n.$3^$
-`.2$?><k$d/0$'23i0$
0>$`‰/</0C$2$N.(
R#$N$N…?$;".0d00?%0V`
;(I$>$0d/1.…?$Kcc{Ycc
?$SLY
{Kc
UFdO[(I#OF.
'[dk$.$–AA5
6*
&$/00<_A*{q$z$C
0C$'?$`(
1.3.5.2. Giai đoạn 2kS0FC3U
T;2/?$#<NO0`
B50d0$[…?$(n.$3!0*
d>"(: 0dG`0C3
^/<#$'?$ ;^$
.$3'#>><5G0AS$
#0?$'C??$i;.$3/
[d>"#.`#2$0
25.`0;^1C"2$—pG$?$(
n.'#>h2#$2a!8$N
'0'^1CN<(:N<#F'
>/Vj†/2j0.<dA></"G
0C'F(
01I1L17G54 P#;
bnF-$$[A$'?$&$.-$Fd#[d
J25MJ27Mk
To#C0C5C2'[&$&$"1(
T•'?$-$'?0C…AAf
A40$8FR(
TI$'?$-$F$[B.0 .
[0>$(
TI$'?$&$.-$F2[d=)0FA\
A40.\(
b n.[5!.[&$[dk
T[!'$Fk€0 !
_AA{.5&$/%(
6L
Tn.[[d<.`$'?$&$.-$k$
.$[.[0$^$$V[
$(
01I1:1ST,
:-$B?$A56$a2$J25MJ54Mk
b|@A%$.#†<?$.N(
b|@A%.$."?k
Tn.[./0CW$'(
Tn.[.AB$[…?$a$CW.$'
#>(
8C2'./3$w}6ccq2@A%
?$&$.3C.3<d2.$[a
[2F<N2@A%?$&$.30<
a dF[[]X;PQR
0h[0.<dJYmM(
wC'&$‚]?$010?.
3$AB\"#2</*cZ.?*Y$
BA?$#(I?$/!0
\`).#(n..A%0C`?$#5
N&$2$/'\ABFV/`
C01\h<V.-= .
N&$2$AAf(|@A%?$&$.3hF&$
25#$-N&$25G\<..
0-$B<_$#`0-$BJqKM(
6Y